See Inside!

List Price

$210.00

Textbook Details

  • EDITION:
    1st Edition
  • ISBN:
    3527320903
  • ISBN-13:
    9783527320905
  • PUB. DATE:
    November 2008
  • PUBLISHER:
    Wiley, John & Sons, Incorporated

Next-Generation Genome Sequencing: Towards Personalized Medicine / Edition 1 by Michal Janitz (Editor)

$210.00 List Price

TEXTBOOKS

Hardcover

Buy

  • Overview
  • EditorialReviews
  • CustomerReviews
  • Features
  • marketplace

Customer Reviews

Not worth the moneyby Anonymous

Customer Rating:
See Detailed Ratings

The price tag on this book is way too high.

What is this, the holy bible of Next gen sequencing?

half of the stuff is outdated already....

Overview -

Next-Generation Genome Sequencing

Product Details

  • Pub. Date: November 2008
  • Publisher: Wiley, John & Sons, Incorporated

Synopsis

Written by leading experts from industry and academia, this comprehensive resource addresses recent developments in next generation DNA sequencing technology and their impact on genome research, drug discovery and health care. As such, it presents a detailed comparative analysis of commercially available platforms as well as insights into alternative, emerging sequencing techniques. In addition, the book not only covers the principles of DNA sequencing techniques but also social, ethical and commercial aspects, the concept of personalized medicine and a five-year perspective of DNA sequencing.

Biography

Dr. Michal Janitz is a group leader at the Department of Vertebrate Genomics at the Max Planck Institute for Molecular Genetics, Berlin. Dr. Janitz scientific interest is focused on technology development related to high-throughput functional genomics using cell array and nanowell-based oligonucleotide fingerprinting. Before joining the MPIMG Dr. Janitz was a postdoc at the German Rheumatism Research Center in Berlin where he also received a Ph.D on studies concerning functional analysis of the MHC class II promoters polymorphisms. He is a member of the German National Genome Research Network and Gerson Lehrman Group Healthcare & Biomedical Council.